Lataa...
Regional Variation in Use of a New Class of Antidiabetic Medication Among Medicare Beneficiaries: The Case of Incretin Mimetics
BACKGROUND: When incretin mimetic (IM) medications were introduced in 2005, their effectiveness compared other less-expensive second-line diabetes therapies was unknown, especially for older adults. Physicians likely had uncertainty about the role of IMs in the diabetes treatment armamentarium. Regi...
Tallennettuna:
| Julkaisussa: | Ann Pharmacother |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4876962/ https://ncbi.nlm.nih.gov/pubmed/25515869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1060028014563951 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|